RNA interference for the treatment of cancer


Autoria(s): Putral, Lisa N.; Gu, Wenyi; McMillan, Nigel A. J.
Contribuinte(s)

J. R. Prous

K. R. Smilkstein et al.

Data(s)

01/01/2006

Resumo

RNA interference (RNAi) is the latest new technology in the field of genetic medicine in which specific genes can be turned off, or silenced, so as to affect a therapeutic outcome. It can be highly specific, works in the nanomolar range and is far more effective than the antisense approaches popular 10-15 years ago. Here we review the field and explore the potential role of RNAi in cancer therapy, highlighting recent progress and examining the hurdles that must be overcome before this promising technology is ready for clinical use. (C) 2006 Prous Science. All rights reserved.

Identificador

http://espace.library.uq.edu.au/view/UQ:80807

Idioma(s)

eng

Publicador

Prous Science

Palavras-Chave #Pharmacology & Pharmacy #Double-stranded-rna #Inhibits Tumor-growth #In-vivo #Human-papillomavirus #Carcinoma-cells #Messenger-rna #Selective Delivery #Cationic Liposomes #Mammalian-cells #Prostate-cancer #CX #321015 Oncology and Carcinogenesis #730108 Cancer and related disorders #111204 Cancer Therapy (excl. Chemotherapy and Radiation Therapy)
Tipo

Journal Article